Literature DB >> 17389304

Ethnic variation in the incidence of ALS: a systematic review.

Simon Cronin1, Orla Hardiman, Bryan J Traynor.   

Abstract

BACKGROUND: The findings of recent genetic polymorphism studies in ALS suggest that the influence of genetic risk factors for the disease may vary by ethnicity. It is now widely accepted that the incidence of ALS is uniform across Caucasian populations, but whether racial variation across other ethnicities exists remains unknown.
METHOD: Systematic review of the known literature on the incidence, prevalence, and mortality of ALS across all ethnicities. To facilitate comparison, studies were grouped according to the type of data presented and examined for sources of case ascertainment and inclusion criteria.
RESULTS: The literature search identified 61 publications. Lower standardized incidence rates were observed in Asian than Caucasian populations. Within the United States, several incidence and mortality studies have identified lower ALS frequency among African American and Hispanic populations than among non-Hispanic Caucasians. These observations are supported by the other data sources.
CONCLUSIONS: The incidence of ALS may be lower among African, Asian, and Hispanic ethnicities than among whites. We conclude with proposals for a prospective epidemiologic study concentrating on non-Caucasian populations.

Entities:  

Mesh:

Year:  2007        PMID: 17389304     DOI: 10.1212/01.wnl.0000258551.96893.6f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  77 in total

Review 1.  Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival.

Authors:  John D Beard; Freya Kamel
Journal:  Epidemiol Rev       Date:  2014-10-31       Impact factor: 6.222

Review 2.  Toward precision medicine in amyotrophic lateral sclerosis.

Authors:  Zhang-Yu Zou; Chang-Yun Liu; Chun-Hui Che; Hua-Pin Huang
Journal:  Ann Transl Med       Date:  2016-01

3.  Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosis.

Authors:  Tian Chen; Radhia Benmohamed; Anthony C Arvanites; Hantamalala Ralay Ranaivo; Richard I Morimoto; Robert J Ferrante; D Martin Watterson; Donald R Kirsch; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2010-10-30       Impact factor: 3.641

Review 4.  Genetics of disc-related disorders: current findings and lessons from other complex diseases.

Authors:  Annu Näkki; Michele C Battié; Jaakko Kaprio
Journal:  Eur Spine J       Date:  2013-07-10       Impact factor: 3.134

Review 5.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

6.  Meta-analytic evaluation of the association between head injury and risk of amyotrophic lateral sclerosis.

Authors:  Yukari Watanabe; Takamitsu Watanabe
Journal:  Eur J Epidemiol       Date:  2017-10-27       Impact factor: 8.082

7.  Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population.

Authors:  Mohamed Kazamel; Gary Cutter; Gwendolyn Claussen; Mohammad Alsharabati; Shin J Oh; Liang Lu; Peter H King
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-03-05       Impact factor: 4.092

8.  Updated Prevalence and Demographic Characteristics for ALS Cases in Texas, 2009-2011.

Authors:  Lindsay Rechtman; Laurie Wagner; Wendy Kaye; John Villanacci
Journal:  South Med J       Date:  2015-08       Impact factor: 0.954

Review 9.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

Review 10.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.